Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Pandion Therapeutics Holdco LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/31/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/29/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/27/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/24/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Mutz Mitchell (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Granted 13,997 options to buy @ $18, valued at $251.9k
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Carroll Jill (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 1,538,724 shares @ $0
Converted 348,469 shares @ $0
Bought 361,111 shares @ $18, valued at $6.5M
Converted 7,846,554 preferred shares @ $0
Converted 1,776,980 preferred shares @ $0
Granted 13,997 options to buy @ $18, valued at $251.9k
07/21/2020 4 JDRF T1D Fund LLC (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 204,313 shares @ $0
Converted 222,020 shares @ $0
Converted 948,225 options to buy @ $0
Converted 1,132,170 preferred shares @ $0
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Carlo Rizzuto (Director) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Granted 13,997 options to buy @ $18, valued at $251.9k
07/21/2020 4 Kakkar Rahul (CEO) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 21,133 shares @ $0
Bought 14,000 shares @ $18, valued at $252k
Granted 27,181 options to buy @ $18, valued at $489.3k
Granted 221,067 options to buy @ $18, valued at $4M
Granted 100,493 options to buy @ $18, valued at $1.8M
Converted 107,768 preferred shares @ $0
07/21/2020 4 Sundy John (Chief Medical Officer) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Bought 2,000 shares @ $18, valued at $36k
Granted 145,420 options to buy @ $18, valued at $2.6M
07/21/2020 4 Stagliano Nancy (Director) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 15,004 shares @ $0
Bought 1,000 shares @ $18, valued at $18k
Granted 3,674 options to buy @ $18, valued at $66.1k
Granted 13,997 options to buy @ $18, valued at $251.9k
Converted 28,620 preferred shares @ $0
Converted 47,898 preferred shares @ $0
07/21/2020 4 Viney Joanne L. (See Remarks) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 21,133 shares @ $0
Bought 1,200 shares @ $18, valued at $21.6k
Granted 56,637 options to buy @ $18, valued at $1M
Granted 58,239 options to buy @ $18, valued at $1M
Converted 107,768 preferred shares @ $0
07/21/2020 4 Frail Donald (Director) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 11,741 shares @ $0
Bought 10,000 shares @ $18, valued at $180k
Granted 4,750 options to buy @ $18, valued at $85.5k
Granted 13,997 options to buy @ $18, valued at $251.9k
Converted 59,872 preferred shares @ $0
07/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2020 4 Freedman Edward D. (COO) has filed a Form 4 on Pandion Therapeutics, Inc.
Txns: Converted 2,348 shares @ $0
Granted 2,112 options to buy @ $18, valued at $38k
Granted 53,131 options to buy @ $18, valued at $956.4k
Granted 660 options to buy @ $18, valued at $11.9k
Converted 11,974 preferred shares @ $0
07/21/2020 8-K Quarterly results
07/17/2020 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
07/17/2020 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
07/17/2020 EFFECT Form EFFECT - Notice of Effectiveness:
07/16/2020 3 Access Industries Holdings LLC (10% Owner) has filed a Form 3 on Pandion Therapeutics, Inc.
07/16/2020 3 GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 3 on Pandion Therapeutics, Inc.
07/16/2020 3 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Pandion Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy